By Richard Lenti
Researchers are calling it a breakthrough – a first-of-its-kind imaging tool to detect myelin damage in people suffering from multiple sclerosis (MS). The test could help physicians diagnose MS earlier, monitor the disease’s progression, and evaluate the effectiveness of treatment.
Scientists at Cleveland’s Case Western Reserve University School of Medicine have developed a molecular probe that can be detected by positron emission tomography (PET) imaging. The new molecular marker, called MeDAS, offers the first non-invasive visualization of myelin integrity of the entire spinal cord.
“While MS originates in the immune system, the damage occurs to the myelin structure of the central nervous system,” said Yanming Wang, PhD, associate professor of radiology and senior author of the study published in the journal Annals of Neurology.
The traditional imaging test for diagnosing MS is magnetic resonance imaging (MRI), which can show inflammation and is helpful at diagnosing the disease in its early stages, but cannot accurately track its progression.
Read more at National Pain Report.
(0) Readers Comments
November 12, 2012
October 08, 2012
September 12, 2012
July 23, 2012
June 26, 2019
Oh boy...Your right we hate to hear this. You know why people in pain
Doesn't the 1.5 billion is spent a year give credence to its possitive
Many MS drugs cause PML and deaths too these drugs all need t
I knew him when he was breaking in at a couple of Los Angeles TV stati
Saying there is a 'twist' is the worst type of spoile